MedTrace Logo

Acne Treatment With Active Patches Which Contains Azelaic Acid, Citric Acid,Salicylic Acid and 2% Ascorbic Acid

NCT01179633 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2010-08-11

No results posted yet for this study

Summary

The purpose of this study was to demonstrate the effect of short treatment with active OPLON patches on Acne.

Conditions

  • Acne Vulgaris

Interventions

DEVICE

OPLON active patch

DEVICE

Sham patch

Sponsors & Collaborators

  • Oplon-Pure Science Ltd.

    lead INDUSTRY

Principal Investigators

  • Avner Shemer, MD · Laniado Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2010-06-30
Completion
2010-06-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01179633 on ClinicalTrials.gov